Skip to main content
. 2019 May 9;12(7):879–888. doi: 10.1016/j.tranon.2019.04.008

Figure 4.

Figure 4

Hematologic analysis at days 5 and 28 after administration of PBS (n = 3, open columns) as a control or 3.3 MBq of 211At-MABG (n = 3, closed columns) as the MTD. Data indicate mean and standard deviation. **P < .01 (two-tailed unpaired Student's t test).